← Overview

Strategic Lens

Pharma and health: India and United States

First country

Second country

In 2025, India sold USD 9.74 billion of pharmaceutical products to United States and bought USD 629 million from it.

Benefits

  • BothTwo-way trade in pharmaceutical products grew 55 percent, from USD 6.67 billion in 2019 to USD 10.4 billion in 2025.

Constraints

  • BothFlows are one-sided: in 2025, India sold USD 9.74 billion of pharmaceutical products, against USD 629 million the other way.

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Last updated on 26 September 2026

The numbers

India's exports to United States: pharmaceutical products

USD billion · 2019 to 2025, calendar years, as reported by India

2019: 6.35Low 6.35 / High 9.742025: 9.74

20196.35
20206.99
20216.62
20226.71
20237.55
20248.72
20259.74

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Data retrieved 26 September 2026

India's imports from United States: pharmaceutical products

USD million · 2019 to 2025, calendar years, as reported by India

2019: 318.1Low 300.8 / High 6292025: 629

2019318.1
2020300.8
2021537
2022432.8
2023503.6
2024563
2025629

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Data retrieved 26 September 2026

More on this relationship

Constraints

  • IndiaIn early 2020 India lifted an export embargo on hydroxychloroquine after President Trump threatened retaliation.

Sources: Wikipedia: India–United States relations (revision of 16 September 2026)

← India and United States